Literature DB >> 35133267

The first International Penile Advanced Cancer Trial (InPACT) opens in Canada! Why additional centers are needed.

Juanita Crook1, Peter C Black2, Philippe E Spiess3, Curtis Pettaway4.   

Abstract

Entities:  

Year:  2022        PMID: 35133267      PMCID: PMC8932418          DOI: 10.5489/cuaj.7704

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.

Authors:  Lance C Pagliaro; Dallas L Williams; Danai Daliani; Michael B Williams; William Osai; Michael Kincaid; Sijin Wen; Peter F Thall; Curtis A Pettaway
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

3.  Identification of high risk pathological node positive penile carcinoma: value of preoperative computerized tomography imaging.

Authors:  Niels M Graafland; Hendrik J Teertstra; A Peter E Besnard; Hester H van Boven; Simon Horenblas
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

4.  The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status.

Authors:  Daniel J Canter; Steve Nicholson; Nick Watkin; Emma Hall; Curtis Pettaway
Journal:  Eur Urol Focus       Date:  2019-06-01

5.  Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study.

Authors:  G S Montana; G M Thomas; D H Moore; A Saxer; C E Mangan; S S Lentz; H E Averette
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038

6.  Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

Authors:  M Flam; M John; T F Pajak; N Petrelli; R Myerson; S Doggett; J Quivey; M Rotman; H Kerman; L Coia; K Murray
Journal:  J Clin Oncol       Date:  1996-09       Impact factor: 44.544

Review 7.  Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.

Authors:  Jan Bogaerts; Matthew R Sydes; Nicola Keat; Andrea McConnell; Al Benson; Alan Ho; Arnaud Roth; Catherine Fortpied; Cathy Eng; Clare Peckitt; Corneel Coens; Curtis Pettaway; Dirk Arnold; Emma Hall; Ernie Marshall; Francesco Sclafani; Helen Hatcher; Helena Earl; Isabelle Ray-Coquard; James Paul; Jean-Yves Blay; Jeremy Whelan; Kathy Panageas; Keith Wheatley; Kevin Harrington; Lisa Licitra; Lucinda Billingham; Martee Hensley; Martin McCabe; Poulam M Patel; Richard Carvajal; Richard Wilson; Rob Glynne-Jones; Rob McWilliams; Serge Leyvraz; Sheela Rao; Steve Nicholson; Virginia Filiaci; Anastassia Negrouk; Denis Lacombe; Elisabeth Dupont; Iris Pauporté; John J Welch; Kate Law; Ted Trimble; Matthew Seymour
Journal:  Eur J Cancer       Date:  2014-12-24       Impact factor: 9.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.